SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001477932-18-003408
Filing Date
2018-07-09
Accepted
2018-07-09 17:22:01
Documents
88

Document Format Files

Seq Description Document Type Size
1 FORM S-1 curr_s1.htm S-1 1218724
2 CODE OF ETHICS curr_ex141.htm EX-14.1 8239
3 CONSENT curr_ex231.htm EX-23.1 2098
10 curr_s1img1.jpg GRAPHIC 2574
11 curr_s1img2.jpg GRAPHIC 3555
  Complete submission text file 0001477932-18-003408.txt   6375945

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT curr-20180331.xml EX-101.INS 1447747
5 XBRL TAXONOMY EXTENSION SCHEMA curr-20180331.xsd EX-101.SCH 66556
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20180331_cal.xml EX-101.CAL 54793
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20180331_def.xml EX-101.DEF 213853
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20180331_lab.xml EX-101.LAB 364040
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20180331_pre.xml EX-101.PRE 339614
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-226102 | Film No.: 18945425
SIC: 2673 Plastics, Foil & Coated Paper Bags
Assistant Director 6